Skip to main content
. Author manuscript; available in PMC: 2016 Nov 1.
Published in final edited form as: Breast Cancer Res Treat. 2015 Oct 22;154(2):275–286. doi: 10.1007/s10549-015-3612-z

Fig. 3.

Fig. 3

STEPP of 5-year breast cancer-free interval (BCFI) in the HR+/HER2- population, according to level of progesterone receptor (PgR) expression, for each of the four cohorts defined by trial and chemotherapy use: (A) SOFT no chemotherapy; (B) TEXT no chemotherapy; (C) TEXT chemotherapy; (D) SOFT prior chemotherapy

Abbreviations: HR+=hormone receptor positive; STEPP=subpopulation treatment effect pattern plot